121 related articles for article (PubMed ID: 38581299)
1. Effects of CD34
Oyama T; Fujiwara SI; Tominaga R; Yokoyama D; Noguchi A; Furuki S; Koyama S; Murahashi R; Nakashima H; Hyodo K; Ikeda T; Kawaguchi SI; Toda Y; Nagayama T; Umino K; Minakata D; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Otsuki I; Ohmine K; Kanda Y
Clin Transplant; 2024 Apr; 38(4):e15313. PubMed ID: 38581299
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
3. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
Lickliter JD; McGlave PB; DeFor TE; Miller JS; Ramsay NK; Verfaillie CM; Burns LJ; Wagner JE; Eastlund T; Dusenbery K; Weisdorf DJ
Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652
[TBL] [Abstract][Full Text] [Related]
4. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ
Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691
[TBL] [Abstract][Full Text] [Related]
5. Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Gauntner TD; Brunstein CG; Cao Q; Weisdorf D; Warlick ED; Jurdi NE; Maakaron JE; Arora M; Betts BC; Bachanova V; Holtan SG; He FC
Transplant Cell Ther; 2022 Feb; 28(2):88-95. PubMed ID: 34774817
[TBL] [Abstract][Full Text] [Related]
6. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
[TBL] [Abstract][Full Text] [Related]
7. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
8. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.
Waller EK; Rosenthal H; Jones TW; Peel J; Lonial S; Langston A; Redei I; Jurickova I; Boyer MW
Blood; 2001 May; 97(10):2948-56. PubMed ID: 11342416
[TBL] [Abstract][Full Text] [Related]
9. Cryopreserved CD34
Konuma T; Kato S; Oiwa-Monna M; Tanoue S; Ogawa M; Isobe M; Tojo A; Takahashi S
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1142-1150. PubMed ID: 28390987
[TBL] [Abstract][Full Text] [Related]
10. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
11. A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.
Cornelissen JJ; van der Holt B; Petersen EJ; Vindelov L; Russel CA; Höglund M; Maertens J; Schouten HC; Braakman E; Steijaert MM; Zijlmans MJ; Slaper-Cortenbach I; Boogaerts MA; Löwenberg B; Verdonck LF
Exp Hematol; 2003 Oct; 31(10):855-64. PubMed ID: 14550800
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between CD34+CD61+ megakaryocyte precursors and platelet engraftment in allogeneic hematopoietic stem cell transplantation].
Zhou LK; Chen HR; Wang HX; Yan HM; Duan LN; Zhu L; Xue M; Liu J; Ji SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1344-9. PubMed ID: 19099641
[TBL] [Abstract][Full Text] [Related]
13. The effect of bone marrow graft composition on pediatric bone marrow transplantation outcomes.
Fabrizio V; Wahlquist A; Hill E; Williams E; Kramer C; Jaroscak J; Duong A; Garrett-Mayer E; Hudspeth M
Pediatr Transplant; 2018 Dec; 22(8):e13287. PubMed ID: 30159974
[TBL] [Abstract][Full Text] [Related]
14. Effect of CD34
Pedraza A; Salas MQ; Rodríguez-Lobato LG; Charry P; Suárez-Lledo M; Martínez-Cibrian N; Doménech A; Solano MT; Arcarons J; de Llobet N; Rosiñol L; Gutiérrez-García G; Avilés FF; Urbano-Ispízua Á; Rovira M; Martínez C
Transplant Cell Ther; 2023 Mar; 29(3):181.e1-181.e10. PubMed ID: 36526259
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
16. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation.
Bittencourt H; Rocha V; Chevret S; Socié G; Espérou H; Devergie A; Dal Cortivo L; Marolleau JP; Garnier F; Ribaud P; Gluckman E
Blood; 2002 Apr; 99(8):2726-33. PubMed ID: 11929759
[TBL] [Abstract][Full Text] [Related]
17. Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.
Elmaagacli AH; Peceny R; Steckel N; Trenschel R; Ottinger H; Grosse-Wilde H; Schaefer UW; Beelen DW
Blood; 2003 Jan; 101(2):446-53. PubMed ID: 12393406
[TBL] [Abstract][Full Text] [Related]
18. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.
Mohty M; Bilger K; Jourdan E; Kuentz M; Michallet M; Bourhis JH; Milpied N; Sutton L; Jouet JP; Attal M; Bordigoni P; Cahn JY; Sadoun A; Ifrah N; Guyotat D; Faucher C; Fegueux N; Reiffers J; Maraninchi D; Blaise D
Leukemia; 2003 May; 17(5):869-75. PubMed ID: 12750699
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
Körbling M; Przepiorka D; Huh YO; Engel H; van Besien K; Giralt S; Andersson B; Kleine HD; Seong D; Deisseroth AB
Blood; 1995 Mar; 85(6):1659-65. PubMed ID: 7888684
[TBL] [Abstract][Full Text] [Related]
20. Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.
Remberger M; Törlén J; Ringdén O; Engström M; Watz E; Uhlin M; Mattsson J
Biol Blood Marrow Transplant; 2015 May; 21(5):889-93. PubMed ID: 25662230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
